SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-000598
Filing Date
2022-01-07
Accepted
2022-01-07 09:00:35
Documents
12
Period of Report
2022-01-06
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K odt-8k_20220106.htm   iXBRL 8-K 34265
  Complete submission text file 0001564590-22-000598.txt   166274

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA odt-20220106.xsd EX-101.SCH 5678
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE odt-20220106_lab.xml EX-101.LAB 20067
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE odt-20220106_pre.xml EX-101.PRE 11931
6 EXTRACTED XBRL INSTANCE DOCUMENT odt-8k_20220106_htm.xml XML 3677
Mailing Address 3 EAST 28TH STREET 10TH FLOOR NEW YORK NY 10016
Business Address 3 EAST 28TH STREET 10TH FLOOR NEW YORK NY 10016 332-206-0935
Odonate Therapeutics, Inc. (Filer) CIK: 0001717452 (see all company filings)

IRS No.: 822493065 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38318 | Film No.: 22516607
SIC: 2834 Pharmaceutical Preparations